FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)
|
6 Months Ended |
Jun. 30, 2025 |
Fair Value Disclosures [Abstract] |
|
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis |
Financial assets and liabilities measured at fair value on a recurring basis are summarized below: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | June 30, 2025 | | December 31, 2024 | Dollars in millions | Level 1 | | Level 2 | | Level 3 | | Level 1 | | Level 2 | | Level 3 | Cash and cash equivalents | | | | | | | | | | | | Money market and other securities | $ | — | | | $ | 8,189 | | | $ | — | | | $ | — | | | $ | 6,559 | | | $ | — | | Marketable debt securities | | | | | | | | | | | | Certificates of deposit | — | | | 800 | | | — | | | — | | | 308 | | | — | | | | | | | | | | | | | | Corporate debt securities | — | | | 514 | | | — | | | — | | | 486 | | | — | | U.S. Treasury securities | — | | | 36 | | | — | | | — | | | 39 | | | — | | Derivative assets | — | | | 282 | | | — | | | — | | | 750 | | | — | | Equity investments | 238 | | | 39 | | | — | | | 247 | | | 42 | | | — | | Derivative liabilities | — | | | 301 | | | — | | | — | | | 247 | | | — | | Contingent consideration liability | | | | | | | | | | | | Contingent value rights(a) | 2 | | | — | | | 592 | | | 2 | | | — | | | 256 | | | | | | | | | | | | | | | | | | | | | | | | | |
(a) Includes the fair value of contingent value rights associated with the Mirati acquisition as further described in "—Note 4. Acquisitions, Divestitures, Licensing and Other Arrangements." The fair value of contingent value rights was estimated using a probability-weighted expected return method and was based on significant unobservable inputs, including the discount rate and the estimated probability and timing of achieving a specified regulatory milestone. During the three months ended June 30, 2025, the change in fair value of $336 million reflected revised assumptions primarily related to the probability of achieving the specified regulatory milestone and was recorded within Other (income)/expense, net.
|
Schedule of Equity Investments |
The following summarizes the carrying amount of equity investments: | | | | | | | | | | | | Dollars in millions | June 30, 2025 | | December 31, 2024 | Equity investments with RDFV | $ | 277 | | | $ | 289 | | Equity investments without RDFV | 848 | | | 863 | | Limited partnerships and other equity method investments | 581 | | | 598 | | Total equity investments | $ | 1,706 | | | $ | 1,750 | |
|
Debt Securities, Trading, and Equity Securities, FV-NI |
The following summarizes the activity related to equity investments. Changes in fair value of equity investments are included in Other (income)/expense, net. | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | Dollars in millions | 2025 | | 2024 | | 2025 | | 2024 | Equity investments with RDFV | | | | | | | | Net (gain)/loss recognized | $ | (4) | | | $ | (36) | | | $ | 1 | | | $ | (122) | | Less: net (gain)/loss recognized on investments sold | 2 | | | — | | | 5 | | | 1 | | Net unrealized (gain)/loss recognized on investments still held | (6) | | | (36) | | | (4) | | | (123) | | | | | | | | | | Equity investments without RDFV | | | | | | | | Upward adjustments | (11) | | | (11) | | | (11) | | | (21) | | Net realized (gain)/loss recognized on investments sold | — | | | (36) | | | 19 | | | (36) | | Impairments and downward adjustments | — | | | 4 | | | 45 | | | 29 | | | | | | | | | | | | | | | | | | Limited partnerships and other equity method investments | | | | | | | | Equity in net (income)/loss of affiliates | 37 | | | (28) | | | 46 | | | (59) | | | | | | | | | | Total equity investment (gains)/losses | $ | 22 | | | $ | (107) | | | $ | 100 | | | $ | (209) | |
|
Schedule of Derivatives and Fair Value |
The following table summarizes the fair value and the notional values of outstanding derivatives: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | June 30, 2025 | | December 31, 2024 | | Asset(a) | | Liability(b) | | Asset(a) | | Liability(b) | Dollars in millions | Notional | | Fair Value | | Notional | | Fair Value | | Notional | | Fair Value | | Notional | | Fair Value | Designated as cash flow hedges | | | | | | | | | | | | | | | Foreign currency exchange contracts | $ | 4,626 | | | $ | 68 | | | $ | 2,296 | | | $ | (151) | | | $ | 6,428 | | | $ | 424 | | | $ | 43 | | | $ | — | | Cross-currency swap contracts | 584 | | | 74 | | | — | | | — | | | 584 | | | 26 | | | 626 | | | (30) | | Designated as net investment hedges | | | | | | | | | | | | | | | | Foreign currency exchange contracts | — | | | — | | | — | | | — | | | 185 | | | 17 | | | — | | | — | | Cross-currency swap contracts | 308 | | | 5 | | | 398 | | | (53) | | | 361 | | | 23 | | | 346 | | | (7) | | Designated as fair value hedges | | | | | | | | | | | | | | | | Interest rate swap contracts | 3,300 | | | 49 | | | 1,255 | | | (7) | | | 1,500 | | | 10 | | | 1,955 | | | (20) | | Not designated as hedges | | | | | | | | | | | | | | | | Foreign currency exchange contracts | 2,855 | | | 69 | | | 3,077 | | | (90) | | | 5,749 | | | 250 | | | 5,243 | | | (173) | | Total return swap contracts(c) | 452 | | | 17 | | | — | | | — | | | — | | | — | | | 443 | | | (17) | |
(a) Included in Other current assets and Other non-current assets. (b) Included in Other current liabilities and Other non-current liabilities. (c) Total return swap contracts hedge changes in fair value of certain deferred compensation liabilities.
|
Derivative Instruments, Gain (Loss) |
The following table summarizes the financial statement classification and amount of (gain)/loss recognized on hedges:
| | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2025 | | Six Months Ended June 30, 2025 | Dollars in millions | | Cost of products sold | | Other (income)/expense, net | | Cost of products sold | | Other (income)/expense, net | Foreign exchange contracts | | $ | 13 | | | $ | 8 | | | $ | (13) | | | $ | 24 | | Cross-currency swap contracts | | — | | | (76) | | | — | | | (126) | | Interest rate swap contracts | | — | | | — | | | — | | | (1) | | Forward interest rate contracts | | — | | | (2) | | | — | | | (3) | | | | | | | | | | | | | Three Months Ended June 30, 2024 | | Six Months Ended June 30, 2024 | Dollars in millions | | Cost of products sold | | Other (income)/expense, net | | Cost of products sold | | Other (income)/expense, net | Foreign currency exchange contracts | | $ | (29) | | | $ | (40) | | | $ | (74) | | | $ | (53) | | Cross-currency swap contracts | | — | | | 7 | | | — | | | 36 | | Interest rate swap contracts | | — | | | 4 | | | — | | | 7 | | Forward interest rate contracts | | — | | | (1) | | | — | | | (2) | |
The following table summarizes the effect of derivative and non-derivative instruments designated as hedges in Other comprehensive income/(loss): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | Dollars in millions | 2025 | | 2024 | | 2025 | | 2024 | Derivatives designated as cash flow hedges | | | | | | | | Foreign exchange contracts gain/(loss): | | | | | | | | Recognized in Other comprehensive income/(loss) | $ | (299) | | | $ | 102 | | | $ | (515) | | | $ | 241 | | Reclassified to Cost of products sold | 13 | | | (29) | | | (13) | | | (74) | | Cross-currency swap contracts gain/(loss): | | | | | | | | Recognized in Other comprehensive income/(loss) | 70 | | | (18) | | | 94 | | | (34) | | Reclassified to Other (income)/expense, net | (73) | | | 10 | | | (121) | | | 41 | | Forward interest rate contract gain/(loss): | | | | | | | | Recognized in Other comprehensive income/(loss) | — | | | — | | | — | | | 131 | | Reclassified to Other (income)/expense, net | (2) | | | (1) | | | (3) | | | (2) | | Derivatives designated as net investment hedges | | | | | | | | Cross-currency swap contracts gain/(loss): | | | | | | | | Recognized in Other comprehensive income/(loss) | (45) | | | 23 | | | (63) | | | 50 | Foreign exchange contracts gain/(loss): | | | | | | | | Recognized in Other comprehensive income/(loss) | (15) | | | 18 | | | (78) | | | 41 | | | | | | | | | | | | | | | | | | | | | | | | | |
|